Director, Center for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern Hospital
Allina Health Minneapolis Heart Institute
Minneapolis, Minnesota, United States
Dr. Sorajja has expertise in valvular and structural heart disease and interventional cardiology. Dr. Sorajja is the national P.I. for multiple clinical trials, including TRILUMINATE, SUMMIT-MAC, EXPAND II, vDyne EFS, and SOAR-EFS. He is highly active in intellectural property development, and has published over 300 manuscripts and book chapters.
Disclosure information not submitted.
CRT 2026 Faculty Agreement to Participate
Saturday, March 7, 2026
8:00 AM - 8:00 PM EST